The largest database of trusted experimental protocols

7 protocols using homoharringtonine

1

Analyzing TGF-β Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies: smad3, p-smad3, smad2, smad4, smad1, smad5, smad8, p15, p21, p27, p57, c-myc, CDK4, CDK6, β-actin, TBP antibodies were purchased from Cell Signaling Technology. Goat anti-mouse antibody, goat anti-rabbit antibody were also from Cell Signaling Technology. TbRI and TbRII inhibitor LY2109761 was purchased from Selleckchem. Homoharringtonine was purchased from Sigma.
+ Open protocol
+ Expand
2

Investigating Unfolded Protein Response in MEFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse embryo fibroblasts (MEFs), including Eif2αA/A, Eif2αS/S, Perk+/+, Perk−/−, Ire1α−/−, Ire1α+/+, Atf6α−/−, and Atf6α+/+ were maintained in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) and 1% of penicillin/streptomycin as described earlier [29 (link)]. MEFs were incubated at 37 °C in humidified 5% CO2 incubator for maintenance. To induce heat stress, MEFs were incubated at 42 °C in humidified 5% CO2 incubators for indicated times. Tunicamycin (Tm, Sigma, St. Louis, MO, USA, T7765), thapsigargin (Tg, Sigma, St. Louis, MO, USA, T9033), tauroursodeoxycholic acid (TUDCA, Calbiochem, St. Louis, MO, USA, 580549), cycloheximide (Sigma, St. Louis, MO, USA, C6255), homoharringtonine (Sigma, St. Louis, MO, USA, SML1091), guanabenz (GA, Sigma, St. Louis, MO, USA, G110) ISRIB (Sigma, St. Louis, MO, USA, SML0843), GSK2606414 (Tocris, Bristol, England, 5107), and 4μ8c (Cayman, Ann Arbor, MI, USA, 22110) were utilized as described in the text.
+ Open protocol
+ Expand
3

Acute Myeloid Leukemia Cell Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
MA9.3ITD (MLL-AF9 fusion gene plus FLT3-ITD mutation; MLL, also known as KMT2A) and MA9.3RAS (MLL-AF9 fusion gene plus NRASG12D mutation) were established by Dr. James Mulloy and cultured in IMDM supplemented with 20% FBS.21 (link) MONOMAC 6, MV4-11, MOLM13, Kasumi-1, THP-1, SKNO-1 and ML-2 are obtained and maintained as previously described.22 (link) Homoharringtonine purchased from Sigma-Aldrich was used in this study.
+ Open protocol
+ Expand
4

Inhibitor Treatment and Downstream Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were incubated for indicated durations and concentrations with the following inhibitors: INK128 (Medchem), 10058-F4 (Sigma), Cycloheximide (Amresco), α-amanitin (Sigma), CX-5461 (Selleckchem), MG-132 (Selleckchem), Homoharringtonine (Sigma), and AZD8055 (Selleckchem). Control cells were treated with DMSO. Inhibitors were withdrawn and cells were washed just prior to downstream analyses. For all CHX release experiments, cells were treated with DMSO or CHX for indicated durations. Cells were washed with PBS before addition of fresh medium and harvesting at indicated time points. For all embryo experiments, inhibitors were added to E4.5 blastocysts for the last 3 hours of culture.
+ Open protocol
+ Expand
5

Broad-Spectrum Antiviral Agent Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ribavirin, MPA, brequanir, and homoharringtonine were purchased from Sigma-Aldrich and dissolved in dimethyl sulfoxide (DMSO). Human IFNα (Sigma-Aldrich, H6166) was dissolved in phosphate-buffered saline (PBS). Stock of JAK inhibitor 1 (SC-204021, Santa Cruz Biotechnology, Santa Cruz, CA, USA) was dissolved in DMSO with a final concentration of 5 mg/ml. A library of 94 safe-in-human broad-spectrum antiviral agents (https://drugvirus.info) was dissolved in DMSO with a stock concentration of 10 mM.
+ Open protocol
+ Expand
6

Protein Synthesis Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Puromycin dihydrochloride (Sigma P8833) – stock at 5 mg/ml in water, Cycloheximide (Sigma C7698–1G) – stock 5 mg/ml in ethanol, Sodium Arsenite (Sigma 35000–1L-R) – stock 50 mM in water, Homoharringtonine (Sigma SML1091–10MG) – stock 10mg/ml in DMSO. The drugs were diluted in warm media to get final working concentrations and cells were treated prior to fixation as follows: Puromycin (100µg/ml for 10 min), Cycloheximide (100µg/ml for 10min), Homoharringtonine – 100µg/ml for 10 mins or 1hr and Sodium Arsenite (2mM for 1 hour).
+ Open protocol
+ Expand
7

Anti-malarial Drug Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vivo growth and in vitro translation measurements were performed using the same drug dilutions. The anti-malarial drugs chloroquine, dihydroartemisinin, lumefantrine, monodesethyl amodiaquine, piperaquine, primaquine, and quinine were a generous gift from Dr. Phil Rosenthal of UCSF. SJ733 was generously provided by Dr. Kip Guy of St. Jude Children’s Research Hospital. All other compounds were purchased from the indicated vendors: DDD107498 (Apexbio #A8711-5), mefloquine hydrochloride (Sigma-Aldrich #M2319), emetine (Sigma-Aldrich #E2375), cycloheximide (Fisher #AC35742-0010), MMV008270 (Vitas-M Laboratory #STK591252), actinomycin D (Sigma-Aldrich #A1410), tubercidin (Sigma-Aldrich #T0642), thapsigargin (Sigma-Aldrich #SML1845), ionomycin (Sigma-Aldrich #407951), thiostrepton (Sigma-Aldrich #598226), bruceantin (Toronto Research Chemicals #B689310), verrucarin A (Sigma-Aldrich #V4877), anisomycin (Sigma-Aldrich #A5862), homoharringtonine (Sigma-Aldrich #SML1091), lactimidomycin (EMD Millipore #506291), nagilactone C (BOC Sciences #24338-53-2), suramin sodium salt (Sigma-Aldrich #S2671), puromycin (Thermo Fisher #A1113803), halofuginone (Sigma-Aldrich #32481).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!